Smith Kline & French Laboratories Ltd

Smith Kline & French Laboratories Ltd, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of GSK plc, and as such, it inherits emissions data and climate commitments from its parent organization.

GSK plc has set ambitious climate targets, which include commitments to reduce greenhouse gas emissions across its operations. These targets are cascaded down to Smith Kline & French Laboratories Ltd, aligning with industry standards and best practices. The initiatives include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which aim to enhance transparency and accountability in climate action.

While specific reduction targets for Smith Kline & French Laboratories Ltd are not detailed, the overarching goals from GSK plc reflect a commitment to achieving significant reductions in Scope 1, 2, and 3 emissions. The company is actively working towards a more sustainable future, although precise figures and timelines for emissions reductions at the subsidiary level remain unspecified.